Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the physician will discuss with each individual patient and set an individualized LDL goal according to current guideline and regulation of National Health Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.

Hyperlipidemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD), and therefore it is beneficial to prevent the risk of ASCVD by controlling the prevalence of hyperlipidemia. According to CEPHEUS Pan-Asia survey, the rate of LDL goal attainment in hyperlipidemic patients of Taiwan was suboptimal, especially in high-risk patients. 2017 Taiwan lipid guideline for high-risk patients has been published and clearly defined the treatment goal of blood LDL-C for high-risk patients. Besides, Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the physician will discuss with each individual patient and set an individualized LDL goal according to current guideline and regulation of National Health Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.

Inclusion Criteria:

• ≥20 years-old
• Abnormal lipid profiles according to 2017 Taiwan Lipid Guideline for High-risk Patients

Exclusion Criteria

• Reject to participate in this study
• Pregnant women
• Prisoner
• Illiteracy
• HIV patients
• Individuals who are mentally retarded, homeless, and handicapped

Patients who are ≥20 years, have abnormal lipid profiles, need lipid-lowering drugs according to 2017 Taiwan Lipid Guideline in Lipid Clinic of Taipei MacKay Memorial Hospital.

We will not provide IPD to other researchers according to IRB regulation.